PredxBio

About:

PredxBio is a computational pathology company developing AI tools to analyze whole slide image pathology samples based on spatial analytics.

Website: https://predxbio.com/

Top Investors: K4 Forum Mumbai Network

Description:

PredxBio is a computational pathology company that develops AI tools to analyze whole slide image pathology samples based on spatial analytics. The company helps clinicians and researchers accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. Its AI-based tool automatically recognizes and classifies regions of interest (ROIs) in H&E-stained and immunohistochemistry slides to help pathologists and biopharma companies use personalized spatial intelligence to make clinical decisions and make therapeutic strategies.

Total Funding Amount:

$1.06M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)predxbio.com

Founders:

Chakra Chennubhotla, Jeffrey Fine, Lansing Taylor, Michael Becich

Number of Employees:

11-50

Last Funding Date:

2024-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai